Cite
APA Citation
Tyler, L. C., Le, A. T., Chen, N., Nijmeh, H., Bao, L., Wilson, T. R., Chen, D., Simmons, B., Turner, K. M., Perusse, D., Kasibhatla, S., Christiansen, J., Dudek, A. Z., & Doebele, R. C. (2022). mET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Thoracic cancer, 13(21), 3032–3041. http://access.bl.uk/ark:/81055/vdc_100169179147.0x000018